Skip to content
Stop using now Drug recall · FDA · Published March 18, 2015

Mylan Methotrexate Recall: Particulate Matter Hazard

Mylan recalls specific lots of Methotrexate Injection due to particulate matter. Check lot numbers and expiration dates for affected vials.

🇺🇸 FDA recall #D-1328-2015DrugMylan ›
Take action

Contact the company

Recalling firmMylan Institutional LLC4901 Hiawatha Dr · Rockford, IL 61103-1287
✎ GovInfoNow plain-language explainer

Mylan Institutional LLC is recalling Methotrexate Injection, USP 50 mg/2 mL because it contains particulate matter. The recall affects two specific lots distributed under Pfizer Labs labeling. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/44836-mylan-institutional-llc-recalls-methotrexate-injection-usp-50-mg-2.

Source Summary by GovInfoNow · govinfonow.com/recall/44836-mylan-institutional-llc-recalls-methotrexate-injection-usp-50-mg-2 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1328-2015

Cite this page

“Mylan Methotrexate Recall: Particulate Matter Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44836-mylan-institutional-llc-recalls-methotrexate-injection-usp-50-mg-2. Based on FDA recall #D-1328-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1328-2015%22&limit=1).

The FDA announced on March 18, 2015, that Mylan Institutional LLC is recalling Methotrexate Injection due to the presence of particulate matter. The Class I recall affects vials distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Mylan
  • Product: Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial
  • Packaging: 5 x 2 mL vials per carton
  • NDC: 0069-0146-01 and 67457-467-99
  • Lot #: 7801082 (Exp. 07/15) and 7801421 (Exp. 09/16)
  • Quantity: 15,095 vials and 300 vials

The hazard

The recall addresses the presence of particulate matter in the Methotrexate Injection. The FDA classified this as a Class I hazard.

Context

GovInfoNow's records show Mylan Institutional LLC has 10 other recalls on record since January 23, 2015. Other recent recalls of similar products include Mylan Thiamine HCl Injection (May 3, 2021), Mylan Amiodarone Injection (August 17, 2020), and Mylan Daptomycin Injection (July 7, 2020). Other recent recalls of similar products include B. Braun Medical Lactated Ringer's Injection (August 12, 2026), Cipla Lanreotide Injection (January 2, 2026), and IMAAVY Injection (September 23, 2026).

How to tell if you have this one

Look for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) in 2 mL single-dose vials. Check the lot numbers: 7801082 with expiration date 07/15, or 7801421 with expiration date 09/16. The product is labeled as distributed by Pfizer Labs (NDC 0069-0146-01) and manufactured for Mylan Institutional LLC (NDC 67457-467-99).

  • Brand
    Mylan
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your vials match lot numbers 7801082 or 7801421.

  2. Stop Using Affected Vials

    Do not use any vials from the recalled lots due to the risk of particulate matter.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Mar 18, 201512. FDA classified it Class I: Aug 13, 201523. Published in FDA’s Enforcement Report: Aug 19, 201534. FDA terminated the recall: Jun 29, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1328-2015 (March 18, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1328-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA